[Mannheimia haemolytica and the pathogenesis of enzootic bronchopneumonia]

Christa Ewers1, Antina Lübke-Becker, Lothar H Wieler

  • 1Institut für Mikrobiologie und Tierseuchen, Fachbereich Veterinärmedizin, Freie Universität Berlin. Ewers.Christa@vetmed.fu-berlin.de

Insights

Mannheimia haemolytica causes severe respiratory disease in cattle and sheep. This review details its virulence factors and pathogenesis, aiding vaccine development for pneumonic pasteurellosis.

Area of Science:

  • Veterinary Microbiology
  • Bacterial Pathogenesis

Context:

  • Mannheimia haemolytica is a primary cause of pneumonic pasteurellosis, a significant respiratory illness in livestock.
  • Disease presentation varies between cattle (serotype A1, A6) and sheep (all serotypes).

Purpose:

  • To review current literature on M. haemolytica virulence factors and pathogenesis.
  • To establish a model for understanding the disease process.
  • To identify potential vaccine candidates.

Summary:

  • M. haemolytica colonizes the respiratory tract, initiating an inflammatory cascade via LPS and leukotoxin.
  • This leads to neutrophilic influx, fibrin accumulation, and lung necrosis (fibronecrotizing pneumonia).
  • Understanding virulence factors is crucial for developing effective vaccines against M. haemolytica.

Impact:

  • Highlights knowledge gaps in M. haemolytica virulence and pathogenesis.
  • Emphasizes the need for further research, including genomics, proteomics, and transcriptomics.
  • Aims to improve vaccine efficacy for pneumonic pasteurellosis in cattle and sheep.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...